skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 473  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses
Material Type:
Article
Add to My Research

Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses

Cancer cell, 2016-09, Vol.30 (3), p.391-403 [Peer Reviewed Journal]

2016 Elsevier Inc. ;Copyright © 2016 Elsevier Inc. All rights reserved. ;ISSN: 1535-6108 ;EISSN: 1878-3686 ;DOI: 10.1016/j.ccell.2016.06.025 ;PMID: 27622332

Full text available

2
Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease
Material Type:
Article
Add to My Research

Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease

Cancer discovery, 2016-12, Vol.6 (12), p.1382-1399

2016 American Association for Cancer Research. ;ISSN: 2159-8274 ;EISSN: 2159-8290 ;DOI: 10.1158/2159-8290.cd-16-0577 ;PMID: 27663893

Full text available

3
Molecular Pathways: Targeting CD96 and TIGIT for Cancer Immunotherapy
Material Type:
Article
Add to My Research

Molecular Pathways: Targeting CD96 and TIGIT for Cancer Immunotherapy

Clinical cancer research, 2016-11, Vol.22 (21), p.5183-5188 [Peer Reviewed Journal]

2016 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-16-0933 ;PMID: 27620276

Full text available

4
Blockade of PD-1/PD-L1 promotes adoptive T-cell immunotherapy in a tolerogenic environment
Material Type:
Article
Add to My Research

Blockade of PD-1/PD-L1 promotes adoptive T-cell immunotherapy in a tolerogenic environment

PloS one, 2015-03, Vol.10 (3), p.e0119483-e0119483 [Peer Reviewed Journal]

COPYRIGHT 2015 Public Library of Science ;COPYRIGHT 2015 Public Library of Science ;2015 Blake et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Blake et al 2015 Blake et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0119483 ;PMID: 25741704

Full text available

5
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
Material Type:
Article
Add to My Research

Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells

Nature immunology, 2017-09, Vol.18 (9), p.1004-1015 [Peer Reviewed Journal]

COPYRIGHT 2017 Nature Publishing Group ;COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Sep 2017 ;Springer Nature America, Inc. 2017. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1529-2908 ;EISSN: 1529-2916 ;DOI: 10.1038/ni.3800 ;PMID: 28759001

Full text available

6
Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy
Material Type:
Article
Add to My Research

Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy

Cancer discovery, 2016-04, Vol.6 (4), p.446-459

2016 American Association for Cancer Research. ;ISSN: 2159-8274 ;EISSN: 2159-8290 ;DOI: 10.1158/2159-8290.cd-15-0944 ;PMID: 26787820

Full text available

7
Assessing Immune-Related Adverse Events of Efficacious Combination Immunotherapies in Preclinical Models of Cancer
Material Type:
Article
Add to My Research

Assessing Immune-Related Adverse Events of Efficacious Combination Immunotherapies in Preclinical Models of Cancer

Cancer research (Chicago, Ill.), 2016-09, Vol.76 (18), p.5288-5301 [Peer Reviewed Journal]

2016 American Association for Cancer Research. ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.can-16-0194 ;PMID: 27503925

Full text available

8
Advancing translational research for colorectal immuno-oncology
Material Type:
Article
Add to My Research

Advancing translational research for colorectal immuno-oncology

British journal of cancer, 2023-10, Vol.129 (9), p.1442-1450 [Peer Reviewed Journal]

2023. The Author(s). ;The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-023-02392-x ;PMID: 37563222

Full text available

9
Agonistic CD40 mAb-Driven IL12 Reverses Resistance to Anti-PD1 in a T-cell-Rich Tumor
Material Type:
Article
Add to My Research

Agonistic CD40 mAb-Driven IL12 Reverses Resistance to Anti-PD1 in a T-cell-Rich Tumor

Cancer research (Chicago, Ill.), 2016-11, Vol.76 (21), p.6266-6277 [Peer Reviewed Journal]

2016 American Association for Cancer Research. ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.CAN-16-2141 ;PMID: 27634762

Full text available

10
No evidence of durable trained immunity after two doses of adenovirus-vectored or mRNA COVID-19 vaccines
Material Type:
Article
Add to My Research

No evidence of durable trained immunity after two doses of adenovirus-vectored or mRNA COVID-19 vaccines

The Journal of clinical investigation, 2023-09, Vol.133 (17) [Peer Reviewed Journal]

COPYRIGHT 2023 American Society for Clinical Investigation ;2023 Stevens et al. 2023 Stevens et al. ;ISSN: 1558-8238 ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/JCI171742 ;PMID: 37471143

Full text available

11
The composition of the gut microbiota following early-life antibiotic exposure affects host health and longevity in later life
Material Type:
Article
Add to My Research

The composition of the gut microbiota following early-life antibiotic exposure affects host health and longevity in later life

Cell reports (Cambridge), 2021-08, Vol.36 (8), p.109564-109564, Article 109564 [Peer Reviewed Journal]

2021 The Author(s) ;Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved. ;ISSN: 2211-1247 ;EISSN: 2211-1247 ;DOI: 10.1016/j.celrep.2021.109564 ;PMID: 34433065

Full text available

12
Plant species dispersed by Galapagos tortoises surf the wave of habitat suitability under anthropogenic climate change
Material Type:
Article
Add to My Research

Plant species dispersed by Galapagos tortoises surf the wave of habitat suitability under anthropogenic climate change

PloS one, 2017-07, Vol.12 (7), p.e0181333-e0181333 [Peer Reviewed Journal]

COPYRIGHT 2017 Public Library of Science ;COPYRIGHT 2017 Public Library of Science ;2017 Ellis-Soto et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Ellis-Soto et al 2017 Ellis-Soto et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0181333 ;PMID: 28727747

Full text available

13
CD96 Is an Immune Checkpoint That Regulates CD8 + T-cell Antitumor Function
Material Type:
Article
Add to My Research

CD96 Is an Immune Checkpoint That Regulates CD8 + T-cell Antitumor Function

Cancer immunology research, 2019-04, Vol.7 (4), p.559-571 [Peer Reviewed Journal]

2019 American Association for Cancer Research. ;ISSN: 2326-6066 ;EISSN: 2326-6074 ;DOI: 10.1158/2326-6066.CIR-18-0637 ;PMID: 30894377

Full text available

14
Megafauna extinction, tree species range reduction, and carbon storage in Amazonian forests
Material Type:
Article
Add to My Research

Megafauna extinction, tree species range reduction, and carbon storage in Amazonian forests

Ecography (Copenhagen), 2016-02, Vol.39 (2), p.194-203 [Peer Reviewed Journal]

2015 Nordic Society Oikos ;Ecography © 2016 Nordic Society Oikos ;2016. This work is published under https://onlinelibrary.wiley.com/terms-and-conditions (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0906-7590 ;EISSN: 1600-0587 ;DOI: 10.1111/ecog.01587

Full text available

15
Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasis
Material Type:
Article
Add to My Research

Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasis

Oncoimmunology, 2018-07, Vol.7 (7), p.e1445949-e1445949 [Peer Reviewed Journal]

2018 Taylor & Francis Group, LLC 2018 ;2018 Taylor & Francis Group, LLC 2018 Taylor & Francis Group, LLC ;ISSN: 2162-4011 ;ISSN: 2162-402X ;EISSN: 2162-402X ;DOI: 10.1080/2162402X.2018.1445949 ;PMID: 29900061

Full text available

16
Forest Elephants: Tree Planters of the Congo
Material Type:
Article
Add to My Research

Forest Elephants: Tree Planters of the Congo

Biotropica, 2009-07, Vol.41 (4), p.459-468 [Peer Reviewed Journal]

Copyright 2009 Association for Tropical Biology and Conservation Inc. ;2009 The Author(s). Journal compilation © 2009 by The Association for Tropical Biology and Conservation ;2009 INIST-CNRS ;ISSN: 0006-3606 ;EISSN: 1744-7429 ;DOI: 10.1111/j.1744-7429.2009.00512.x ;CODEN: BTROAZ

Full text available

17
Early-Life Antibiotic-Driven Dysbiosis Leads to Dysregulated Vaccine Immune Responses in Mice
Material Type:
Article
Add to My Research

Early-Life Antibiotic-Driven Dysbiosis Leads to Dysregulated Vaccine Immune Responses in Mice

Cell host & microbe, 2018-05, Vol.23 (5), p.653-660.e5 [Peer Reviewed Journal]

2018 Elsevier Inc. ;Copyright © 2018 Elsevier Inc. All rights reserved. ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2018.04.009 ;PMID: 29746836

Full text available

18
Invasion by Cedrela odorata threatens long distance migration of Galapagos tortoises
Material Type:
Article
Add to My Research

Invasion by Cedrela odorata threatens long distance migration of Galapagos tortoises

Ecology and evolution, 2024-02, Vol.14 (2), p.e10994-n/a [Peer Reviewed Journal]

2024 The Authors. published by John Wiley & Sons Ltd. ;2024 The Authors. Ecology and Evolution published by John Wiley & Sons Ltd. ;2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2045-7758 ;EISSN: 2045-7758 ;DOI: 10.1002/ece3.10994 ;PMID: 38357592

Full text available

19
OX40‐targeted immune agonist antibodies induce potent antitumor immune responses without inducing liver damage in mice
Material Type:
Article
Add to My Research

OX40‐targeted immune agonist antibodies induce potent antitumor immune responses without inducing liver damage in mice

FASEB bioAdvances, 2021-10, Vol.3 (10), p.829-840 [Peer Reviewed Journal]

2021 The Authors. published by Wiley Periodicals LLC on behalf of The Federation of American Societies for Experimental Biology ;2021 The Authors. FASEB BioAdvances published by Wiley Periodicals LLC on behalf of The Federation of American Societies for Experimental Biology. ;2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2573-9832 ;EISSN: 2573-9832 ;DOI: 10.1096/fba.2021-00039 ;PMID: 34632317

Full text available

20
Concomitant or delayed anti-TNF differentially impact on immune-related adverse events and antitumor efficacy after anti-CD40 therapy
Material Type:
Article
Add to My Research

Concomitant or delayed anti-TNF differentially impact on immune-related adverse events and antitumor efficacy after anti-CD40 therapy

Journal for immunotherapy of cancer, 2020-11, Vol.8 (2), p.e001687 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020 ;ISSN: 2051-1426 ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2020-001687 ;PMID: 33199513

Full text available

Results 1 - 20 of 473  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (206)

Refine My Results

Creation Date 

From To
  1. Before 1978  (16)
  2. 1978 To 1991  (33)
  3. 1992 To 2001  (117)
  4. 2002 To 2012  (154)
  5. After 2012  (159)
  6. More options open sub menu

Language 

  1. English  (439)
  2. French  (60)
  3. German  (28)
  4. Japanese  (26)
  5. Portuguese  (9)
  6. Norwegian  (7)
  7. Spanish  (5)
  8. Swedish  (2)
  9. Hebrew  (2)
  10. Turkish  (2)
  11. Czech  (2)
  12. Chinese  (2)
  13. Finnish  (2)
  14. Hungarian  (1)
  15. Danish  (1)
  16. Slovak  (1)
  17. More options open sub menu

Searching Remote Databases, Please Wait